德福科技表示，本次终止收购卢森堡铜箔100%股权不会影响公司的正常生产经营，不会对公司的财务 状况产生不利影响。公司将继续围绕既定发展战略，加快推进高端电子电路铜箔业务，推动公司持续稳 健发展。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 1月11日晚，德福科技（301511）公告称，公司原计划以1.74亿欧元（按当前汇率，折合人民币约14.13 亿元）收购境外公司Circuit Foil Luxembourg S.a.r.l．（以下简称"卢森堡铜箔"、"标的公司"）100%股 权。但因本次交易未能获得境外有关部门的无条件批准，经公司与交易对方友好协商，决定终止本次收 购。 收购未能获得境外有关部门的无条件批准 回溯来看， 2025年7月29日晚，德福科技披露称，公司与Volta Energy Solutions S．à．r.l（以下简称"卖 方"）签署了《股权购买协议》，德福科技拟收购卖方旗下卢森堡铜箔100%股权，标的公司100%企业 价值为2.15亿欧元，扣除双方约定的调整项目后，计算得到标的公司100%股权收购价格为1.74亿欧元。 标的公司卢森堡铜箔成立于1960年，拥 ...

继今年4月份成功并购厄瓜多尔凯歌豪斯金矿之后，洛阳钼业再披露重大投资计划——12月15日，洛阳钼业宣布，将以总计10.15亿美元的对价收购加拿大矿 业企业Equinox Gold位于巴西四个金矿资产的100%权益。 据了解，今年是洛阳钼业加速布局全球优质资产与战略资源的关键一年。上半年，洛阳钼业进行管理层大调整，引进多位具有丰富海外并购经验的高管，再 次迈开了其海外资产并购的步伐。此次并购巴西金矿资产是洛阳钼业在黄金资源上又一重大战略布局，若交易顺利完成，其黄金业务年产量将新增约8吨。 摆脱困境顺利上市 洛阳钼业是一家全球化的大型有色金属矿业企业，业务覆盖多大洲，在行业内处于全球领先地位。2007年，公司在港交所挂牌上市，2012年又登陆上交所， 完成"A+H"两地上市布局。 以洛阳钼业目前的营收规模与资产总额来看，很难想象其曾经也是一家濒临破产的企业。洛阳钼业的前身是原冶金部在河南省洛阳市栾川县设立的小型钼选 厂。栾川县地处山区，矿产资源丰富，尤其是钼矿探明储量世界第三、亚洲第一。这为洛阳钼业的前身提供了得天独厚的资源条件。 1996年至2002年，国内外钼价持续低迷，市场需求不足，导致企业产品销售困难，收 ...

继今年4月份成功并购厄瓜多尔凯歌豪斯金矿之后，洛阳钼业再披露重大投资计划——12月15日，洛阳钼业宣布，将以总计10.15亿美元的对价收购加拿大矿 业企业Equinox Gold位于巴西四个金矿资产的100%权益。 开启"买买买"模式 自步入良性发展轨道，洛阳钼业借助一系列收购实现了从国内钼钨企业到全球化综合矿业集团的跨越。尤其是在A股上市之后收购动作愈发密集，覆盖铜 钴、铌磷、镍钴、黄金等多个矿产领域，还纳入了全球顶尖金属贸易平台。 2013年12月，洛阳钼业以8.2亿美元的价格收购澳大利亚北帕克斯铜金矿（NPM）80%权益，这是公司首次大规模海外矿产收购，为其后续全球化矿产布局 积累了海外项目运营和管理的初步经验。 据了解，今年是洛阳钼业加速布局全球优质资产与战略资源的关键一年。上半年，洛阳钼业进行管理层大调整，引进多位具有丰富海外并购经验的高管，再 次迈开了其海外资产并购的步伐。此次并购巴西金矿资产是洛阳钼业在黄金资源上又一重大战略布局，若交易顺利完成，其黄金业务年产量将新增约8吨。 摆脱困境顺利上市 洛阳钼业是一家全球化的大型有色金属矿业企业，业务覆盖多大洲，在行业内处于全球领先地位。2007年，公司 ...

上周五（12月12日），中国江西铜业再次提高对英国上市公司SolGold的收购报价至每股28便士，总价值约8.42亿英镑（11.3亿美元）。11月23日，江西铜 业首次提出非约束性收购提议遭到拒绝后，于11月28日再次出价每股26便士，同样被董事会否决。最新的28便士报价是这家中国铜业巨头三周内第三次出 价。 SolGold Plc于2005年在澳大利亚布里斯班创立，现总部位于英国伦敦，其核心资产就是南美洲的顶级铜金矿项目-Cascabel项目，这也是江西铜业锲而不舍 的原因之所在。 Cascabel项目位于厄瓜多尔因巴布拉省，是近十年南美发现的规模最大、品位最优的未开发铜金矿之一。SolGold 将其定位为 "可支撑 50 年以上开采的多 代人资产"，目标是建成南美洲前二十大铜金一体化矿山 Cascabel项目主要的Alpala矿床拥有探明、控制及推断资源量，包括铜1220万吨、金3050万盎司、银10230万盎司。据公开资料显示，其铜矿平均品位达到 0.78%，而当前全球铜矿的平均开采品位已降至0.5%左右，部分老矿的品位甚至低于0.3%。高品位意味着更低的开采成本、更高的生产效率，在铜价波动 的周期中， ...

Group 1: R&D Progress and Market Position - The LZM012 project has completed Phase III clinical trials for psoriasis and ankylosing spondylitis, with a formal market application expected next month for psoriasis and in the first half of next year for ankylosing spondylitis [2][3] - LZM012 is the first domestic Phase III study targeting psoriasis with PASI100 as the primary endpoint, showing superior efficacy compared to existing treatments, with fewer administration cycles and lower overall costs [2][3] - The JP-1366 tablet of the P-CAB product has been submitted for market approval, with the injection form entering Phase II clinical trials, capitalizing on the growing P-CAB market projected to reach approximately CNY 1.25 billion in 2024, an 81% year-on-year increase [3][4] Group 2: Strategic Product Development - The company is focusing on the schizophrenia long-acting injection market, with the recently approved aripiprazole microsphere being the first of its kind in China, included in the 2025 guidelines for schizophrenia treatment [4][5] - The company is advancing a new generation KCNQ2/3 activator, NS-041, which is a first-class new drug with unique molecular design, targeting both epilepsy and depression indications [5] - The company has established a comprehensive product pipeline for GnRH-a long-acting release formulations, with the approval of the first microsphere product and plans for further submissions, enhancing treatment options for various conditions [6][7] Group 3: Financial Health and Strategic Acquisitions - The company maintains a robust cash reserve, allowing for dividends, buybacks, daily operations, R&D investments, and potential strategic acquisitions [8][9] - A planned acquisition of a Vietnamese company is underway, marking the first acquisition of a Vietnamese pharmaceutical company by a Chinese enterprise, with ongoing compliance with local regulations [9] - The company aims to focus on strategic partnerships in areas such as digestion, mental health, cardiovascular, metabolic, and autoimmune diseases, targeting projects with patent barriers and commercialization potential [9]

Core Viewpoint - Mindray Medical has submitted an application for overseas listing on the Hong Kong Stock Exchange, aiming to raise funds for global R&D, expanding its digital healthcare ecosystem, exploring potential acquisitions, and enhancing its global sales network and supply chain capabilities [1][4]. Financial Performance - The company's performance has significantly declined, with a notable drop in revenue and net profit in the first three quarters of 2025. Revenue was 25.834 billion yuan, a year-on-year decrease of 12.38%, while net profit fell to 7.570 billion yuan, down 28.83% [2][4]. - The domestic business has been particularly hard hit, with revenue from mainland China dropping to 8.411 billion yuan in the first half of 2025, a decline of 33.38%, reducing its business share from nearly 60% to about 50% [4][6]. Business Segments - The three core business lines—life information and support, in vitro diagnostics, and medical imaging—have all experienced declines. Life information and support revenue fell by 31.59%, in vitro diagnostics by 16.11%, and medical imaging by 22.51% in the first half of 2025 [6][10]. Market Position and Strategy - Mindray Medical aims to rank among the top 10 global medical device companies by 2030, with a target of increasing overseas revenue to over 70%. As of 2025, it ranked 25th in the global medical device company list, showing a slight improvement from the previous year [10][12]. - The company has a strong cash position, with 17.133 billion yuan in cash and a low debt ratio of 25.3%, indicating a solid financial structure [10][11]. Dividend Policy - Since its IPO in 2018, Mindray has consistently paid dividends, totaling 35.336 billion yuan, with an average payout ratio exceeding 55%. The company has continued to increase its dividend payments into 2025 [7][8].

【导读】摩根士丹利证券（中国）CEO钱菁称，中国企业跨境投资已迈入高质量发展阶段 中国基金报记者 储是 11月12日至13日，上海证券交易所国际投资者大会拉开帷幕。摩根士丹利证券（中国）有限 公司首席执行官钱菁在并购专场上，就中国企业海外并购的最新趋势及成功要素发表见解。 中国企业海外并购三大趋势凸显 其次，民营企业"出海"拓展国际市场势头强劲。新能源等领域的国内龙头企业，正通过引入 海外主权财富基金或私募股权基金的投资，为其全球业务扩张提供资金支持，加速国际市场 渗透。 第三， 外资聚焦中国优势产业。外资正积极投资于中国的先进制造业与生物医药等优势产 业。 钱菁提到某中国生物医药公司与国际制药巨头达成的独家许可协议，引发国际市场对中国创 新药资产价值的系统性重估；某跨国汽车集团对中国新能源车企的少数股权收购，则实现了 中国新能源整车平台技术的首次对外输出与资本合作。 促成并购的四大核心要素 谈及促成成功并购交易的核心要素，钱菁将其归纳为四点： 第一， 清晰的战略规划是成功的前提，企业需明确并购目标与战略意图。 第二，相通的企业文化同样至关重要，除了常规的业务与财务尽调，还需深入了解目标公司 的企业文化，这直 ...

Core Viewpoint - The company, Huichuan Technology, is focusing on international business expansion, particularly in Europe and emerging markets, to drive growth [1] Group 1: International Expansion Strategy - The company plans to prioritize its international business development in Europe, which hosts many leading equipment manufacturing clients [1] - Southeast Asia, South America, Korea, and the Middle East are identified as regions with significant growth potential, with Southeast Asia and the Middle East showing notable growth in the first half of the year [1] Group 2: M&A Activities - The company is actively seeking suitable acquisition targets, especially in the European market, focusing on companies with brand influence and independent management systems [1] - Mergers and acquisitions are considered a key strategy for rapid expansion into overseas markets [1]

Core Viewpoint - The acquisition of French GMD Group by Dongshan Precision is a strategic move to enhance its presence in the European automotive parts market, despite concerns raised by the recent incident involving Anshi Semiconductor [2][5]. Group 1: Acquisition Details - Dongshan Precision's wholly-owned subsidiary DSBJ PTE.LTD has successfully acquired 100% of GMD Group for approximately €100 million, completing the debt restructuring [2][3]. - The acquisition process began in May 2023, with all preconditions met and relevant documents signed, allowing GMD Group to be included in Dongshan's consolidated financial statements starting November 1, 2025 [2][3]. - GMD Group, established in 1986, is a leading player in the European automotive parts industry, generating annual revenues of €1 billion and employing over 6,600 staff across 46 factories in 12 countries [3][4]. Group 2: Financial Performance - GMD Group reported audited revenues of €983 million and a net loss of €6 million for 2023, with projected revenues of €1.012 billion and a net profit of €3 million for 2024 [4]. Group 3: Strategic Implications - The acquisition aims to implement a dual-driven strategy to increase market share in the automotive parts sector and establish a European industrial footprint, thereby accelerating Dongshan's globalization efforts [4][6]. - The company anticipates leveraging GMD Group's business and influence to expand its global automotive client base, positively impacting its financial health and operational quality [4][8]. Group 4: Risk Management - Dongshan Precision has expressed confidence in avoiding risks similar to those faced by Anshi Semiconductor, citing significant differences between the automotive parts and semiconductor industries [5][6]. - The company has acknowledged potential risks related to cross-border integration and market performance, including differences in management systems and economic fluctuations [6][7].

Core Insights - The global mining market is undergoing significant changes, with leading companies like Zijin Mining, Luoyang Molybdenum, Shandong Gold, and Western Mining enhancing their scale and optimizing resource structures through mergers and acquisitions [1] Group 1: Resource Integration - The shift in mining resource integration is moving from "dispersed layout" to "system optimization," with a focus on stabilizing and strengthening supply chains [2] - The demand for key minerals such as copper, lithium, cobalt, and nickel is increasing due to the rise of industries like renewable energy and artificial intelligence, leading to a profound change in global mineral demand structure [2] - The Chinese government has provided clear strategic directions for resource integration, emphasizing the need for effective exploration and project layout to avoid redundant low-level construction [2] Group 2: Value Creation - Mining companies are transitioning from relying on "cyclical profits" to "restructuring industry chain value," seeking more stable and sustainable value creation models [3] - Companies are extending vertically into high-value areas such as semiconductor materials and energy battery materials, aiming for geometric growth in resource value [3] - Horizontal collaboration is increasing, with upstream mining companies forming deep partnerships with downstream application firms to create a new supply-demand relationship characterized by shared risks and benefits [3] Group 3: Development Drivers - The mining industry is moving from "resource dependence" to "technology innovation-driven" development, with technological advancements becoming crucial for enhancing core competitiveness [4] - Innovations in exploration and mining, such as smart mining and efficient ore selection, are unlocking the potential of low-grade and difficult-to-process resources [4] - Companies are focusing on building technological moats to ensure production efficiency and cost control, which is essential for sustainable development [4] Group 4: Overseas Mergers and Acquisitions - The focus of overseas mergers and acquisitions is shifting from "asset acquisition" to "capability output," emphasizing the importance of global operational capabilities and localized value creation [5] - Successful international mining companies integrate their capital, technology, and market advantages with the resource endowments and development needs of host countries [5] - Future competition in the mining sector will hinge on resource integration capabilities, industry chain collaboration, technological innovation, and global operational capabilities [5]